Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia With Metabolic Syndrome: A Randomized Controlled Trial

NCT05766540 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences, Bhubaneswar as lead sponsor.

NCT NCT05766540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05766540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia With Metabolic Syndrome: A Randomized Controlled Trial
Lead sponsor
All India Institute of Medical Sciences, Bhubaneswar
Phase
Phase 4
Overall status
Unknown status
Start date
August 20, 2023
Completion date
December 31, 2023
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

difference in the change in cardiovascular risk in treatment resistant schizophrenia